Naloxegol for Opioid-Induced Constipation in Patients with Noncancer PainWilliam D. Chey, Jan Tack, Jaakko Lappalainen et al.|New England Journal of Medicine|2014Cited by 331
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipationLynn R. Webster, Mark Sostek, Michael A. Eldon et al.|Pain|2013Cited by 116
Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipationLynn R. Webster, Mark Sostek, William D. Chey et al.|Alimentary Pharmacology & Therapeutics|2014Cited by 116
A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipationLynn R. Webster, Jaakko Lappalainen, Ulysses Diva et al.|Journal of Opioid Management|2016Cited by 17